pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›calendar
  3. ›device recall
device recall
save

Fresenius Kabi USA, LLC device recall (Cls II)

November 3, 2025updated 6mo ago
community read0 votes

Ivenix Infusion System (IIS), Large Volume Pump. Model Number: LVP-0004. — Reason: Downstream Occlusion alarms may occur during procedures using low flow infusion rates when a check valve* is added to the Ivenix Administration Set. — Status: Ongoing

view source ↗
Data sources
fda device recalls
last refreshed 6mo ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

same company · ±60 days · 6

  • device recallFresenius Kabi USA, LLC device recall (Cls I)Nov 3, 2025
  • approvalCONEXXENCE: CONEXXENCE (DENOSUMAB-BNHT) — FDA approvalOct 29, 2025
  • approvalGLYCOPYRROLATE — FDA approvalOct 27, 2025
  • approvalDALBAVANCIN HYDROCHLORIDE: DALBAVANCIN HYDROCHLORIDE — FDA approvalNov 10, 2025
  • approvalDALBAVANCIN HYDROCHLORIDE — FDA approvalOct 23, 2025
  • device recallFresenius Kabi USA, LLC device recall (Cls I)Nov 14, 2025

🐶 often sniffed alongside

top 8
  • tagApproval258 co-mentions · 129 sources
  • drugRNS-60236 co-mentions · 149 sources
  • drugDIPRIVAN78 co-mentions · 39 sources
  • drugPROPOFOL39 co-mentions · 39 sources
  • drugDILAUDID-HP38 co-mentions · 19 sources
  • tagRecall33 co-mentions · 20 sources
  • drughydromorphone hydrochloride ER19 co-mentions · 19 sources
  • drugHYDROMORPHONE HYDROCHLORIDE19 co-mentions · 19 sources

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?